Table 3.
Product | Incorporated drug | Status | Company |
---|---|---|---|
Genexol PM | Paclitaxel | Marketed | Samyang |
Estrasorb | Estrogen | Marketed | Novavax |
Medicelle | DACH-platin-PEG-polyglutamic acid | phase I/II | NanoCarrier |
Flucide | Anti-influenza | phase I/II | Nano Viricides |
Basulin | Insulin | phase II/III | Flamel Technologies |
DO/NDR/02 | Paclitaxel | phase I/II | Dabur Research Foundation |
NK-911 | Doxorubicin | phase II | Nippon Kayaku Co. |
NK-105 | Paclitaxel | phase II/III | Nippon Kayaku Co. |
NK-012 | SN-38 | phase II | Nippon Kayaku Co. |
NC-6004 | Cisplatin | phase III | Nanocarrier Co. |
NC-4016 | Oxaliplatin | phase I/II | Nanocarrier Co. |
SP-1049C | Doxorubicin | phase II/III | SupratekPharma Inc. |
NC-6300 | Epirubicin | phase I/II | Nanocarrier Co. |